Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT06029166

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06029166
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06029166. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-10-01 (anticipated); primary completion 2026-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors
Acronym
IRAF-ISCM
Intervention (Device)
Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
Lead sponsor
University Hospital, Caen (class: other)
Collaborator
University Hospital, Marseille (class: other)
Collaborator
Groupe Hospitalier Pitie-Salpetriere (class: other)
Collaborator
European Georges Pompidou Hospital (class: other)
Collaborator
Hôpital Necker-Enfants Malades (class: other)
Collaborator
Saint Antoine University Hospital (class: other)
Collaborator
Hospices Civils de Lyon (class: other)
Collaborator
Centre Hospitalier Universitaire de Saint Etienne (class: other)
Collaborator
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct06029166
Content hash
9b5fd59c43921249aa0ce403ead6db94567960ca1269b27e89b0f7b6502ce71a